These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 16206598

  • 21. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
    Kolomoets NM, Baksheev VI, Uvaĭsova KU.
    Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710
    [Abstract] [Full Text] [Related]

  • 22. [Clinical outcomes of trimetazidine in patients with acute ST segment elevation myocardial infarction without ST segment resolution after primary percutaneous coronary intervention].
    Peng JJ, Ma ZM, Ren WL, Ren LH, Lei LC, Liang Y.
    Zhonghua Yi Xue Za Zhi; 2009 May 26; 89(20):1399-401. PubMed ID: 19671333
    [Abstract] [Full Text] [Related]

  • 23. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
    Hudson MP, Armstrong PW, Ruzyllo W, Brum J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):15-20. PubMed ID: 16814643
    [Abstract] [Full Text] [Related]

  • 24. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct 04; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 25. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 05; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 29. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing.
    Beohar N, Flaherty JD, Davidson CJ, Vidovich M, Singhal S, Rapp JA, Erdogan A, Lee DC, Rammohan C, Brodsky A, Wu E, Pieper K, Virmani R, Bonow RO, Mehta J.
    Catheter Cardiovasc Interv; 2007 Feb 01; 69(2):257-66. PubMed ID: 17253607
    [Abstract] [Full Text] [Related]

  • 30. Left ventricular remodeling after anterior wall acute myocardial infarction in modern clinical practice (from the REmodelage VEntriculaire [REVE] study group).
    Savoye C, Equine O, Tricot O, Nugue O, Segrestin B, Sautière K, Elkohen M, Pretorian EM, Taghipour K, Philias A, Aumégeat V, Decoulx E, Ennezat PV, Bauters C, REmodelage VEntriculaire study group.
    Am J Cardiol; 2006 Nov 01; 98(9):1144-9. PubMed ID: 17056315
    [Abstract] [Full Text] [Related]

  • 31. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov 01; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 32. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J.
    Circulation; 2008 Aug 19; 118(8):818-27. PubMed ID: 18678774
    [Abstract] [Full Text] [Related]

  • 33. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 19; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 34. [Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome].
    Kastanaian AA, Nelasov NIu, Eroshenko OL, Kazarian NB, Drobotia NV.
    Kardiologiia; 2003 May 19; 43(9):21-7. PubMed ID: 14593366
    [Abstract] [Full Text] [Related]

  • 35. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling.
    Chang SA, Chang HJ, Choi SI, Chun EJ, Yoon YE, Kim HK, Kim YJ, Choi DJ, Sohn DW, Helm RH, Lardo AC.
    Am J Cardiol; 2009 Jul 01; 104(1):19-23. PubMed ID: 19576315
    [Abstract] [Full Text] [Related]

  • 36. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R, Zhang Y, Zhang M, Li XC, Cai H, Chen WQ, Zhu H, Ge ZM, Zhang W.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 30; 85(45):3199-204. PubMed ID: 16405840
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of balloon-based distal protection during primary percutaneous coronary intervention on early and late infarct size and left ventricular remodeling: a pilot study using serial contrast-enhanced magnetic resonance imaging.
    Hahn JY, Gwon HC, Choe YH, Rhee I, Choi SH, Choi JH, Lee SH, Hong KP, Park JE.
    Am Heart J; 2007 Apr 30; 153(4):665.e1-8. PubMed ID: 17383309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.